CDC Emerging Infectious Diseases Panel Summary from the 2000 Emerging Infectious Diseases Conference in Atlanta, Georgia Philip R. Krause Food and Drug Administration, Bethesda, Maryland, USA A discussion of adventitious agents and vaccines is pertinent in the context of emerging infectious diseases. Many novel vaccines are produced in animal cell substrates, and emerging infectious diseases […]
NIH Funding Bioterror Vaccines
Posted in ‘Drug Discovery & Development 08 October 2010 The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced three new contracts to fund research on vaccines to protect against emerging infectious diseases and biological threats that could be used in a terror attack. Each project focuses on […]
